Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TQB-3454 by Chia Tai Tianqing Pharmaceutical Group for Astrocytoma: Likelihood of Approval
TQB-3454 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase I for Astrocytoma. According to...
Data Insights
TQB-3454 by Chia Tai Tianqing Pharmaceutical Group for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
TQB-3454 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase III for Bile Duct Cancer...